受託解析実績・研究成果・新技術

受託解析実績

2019年度～2021年度（国立研究開発法人医薬基盤・健康・栄養研究所：2019年10月1日～2021年9月1日）
　アカデミア　76件　製薬企業　7件　その他企業　7件

2021年度（第1期：2021年9月2日～2022年7月31日）
　アカデミア　18件　製薬企業　6件　その他企業　2件

2022年度（第2期：2022年8月1日～2023年7月31日）
　アカデミア　件　製薬企業　件　その他企業　件

研究成果

2023年

  1. Takimoto, Y., Tsubamoto, H., Taniguchi, R., Sakata, K., Takada, Y., Adachi, J., Tomonaga, T., Ueda, T., Nakagawa, K., Narita, S., Wakimoto, Y.U., and Shibahara, H. (2023). Itraconazole Repolarizes Tumor-associated Macrophages and Suppresses Cervical Cancer Cell Growth. Anticancer Res 43, 569-580.

2022年

  1. Adachi, J., Kakudo, A., Takada, Y., Isoyama, J., Ikemoto, N., Abe, Y., Narumi, R., Muraoka, S., Gunji, D., Hara, Y., Katayama, R., and Tomonaga, T. (2022). Systematic identification of ALK substrates by integrated phosphoproteome and interactome analysis. Life Sci Alliance 5, e2021012025.
  2. Muraoka, S., Hirano, M., Isoyama, J., Nagayama, S., Tomonaga, T., and Adachi, J. (2022). Comprehensive proteomic profiling of plasma and serum phosphatidylserine-positive extracellular vesicles reveals tissue-specific proteins. iScience 25, 104012.
  3. Muraoka, S., Hirano, M., Isoyama, J., Ishida, M., Tomonaga, T., and Adachi, J. (2022). Automated Proteomics Sample Preparation of Phosphatidylserine-Positive Extracellular Vesicles from Human Body Fluids. ACS Omega 7, 41472-41479.
  4. Kasahara, K., Narumi, R., Nagayama, S., Masuda, K., Esaki, T., Obama, K., Tomonaga, T., Sakai, Y., Shimizu, Y., and Adachi, J. (2022). A large-scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer. Cancer Med.
  5. Tomiyama, E., Fujita, K., Matsuzaki, K., Narumi, R., Yamamoto, A., Uemura, T., Yamamichi, G., Koh, Y., Matsushita, M., Hayashi, Y., Hashimoto, M., Banno, E., Kato, T., Hatano, K., Kawashima, A., Uemura, M., Ukekawa, R., Takao, T., Takada, S., Uemura, H., Adachi, J., Tomonaga, T., and Nonomura, N. (2022). EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer. Br J Cancer 127, 1312-1323.
  6. Shirai, K., Hikita, H., Sakane, S., Narumi, R., Adachi, J., Doi, A., Tanaka, S., Tahata, Y., Yamada, R., Kodama, T., Sakamori, R., Tatsumi, T., Mita, E., Tomonaga, T., and Takehara, T. (2022). Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients. PLoS One 17, e0271020.
  7. Kajiwara, K., Chen, P.K., Abe, Y., Okuda, S., Kon, S., Adachi, J., Tomonaga, T., Fujita, Y., and Okada, M. (2022). Src activation in lipid rafts confers epithelial cells with invasive potential to escape from apical extrusion during cell competition. Curr Biol 32, 3460-3476 e3466.
  8. Hirano, H., Abe, Y., Nojima, Y., Aoki, M., Shoji, H., Isoyama, J., Honda, K., Boku, N., Mizuguchi, K., Tomonaga, T., and Adachi, J. (2022). Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer. Sci Rep 12, 4419.
  9. Futami, Y., Takeda, Y., Koba, T., Narumi, R., Nojima, Y., Ito, M., Nakayama, M., Ishida, M., Yoshimura, H., Naito, Y., Fukushima, K., Takimoto, T., Edahiro, R., Matsuki, T., Nojima, S., Hirata, H., Koyama, S., Iwahori, K., Nagatomo, I., Shirai, Y., Suga, Y., Satoh, S., Futami, S., Miyake, K., Shiroyama, T., Inoue, Y., Adachi, J., Tomonaga, T., Ueda, K., and Kumanogoh, A. (2022). CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis by proteomics of serum extracellular vesicles. Int Immunol 34, 327-340.

2021年

  1. Iwasaki, Y.W., Sriswasdi, S., Kinugasa, Y., Adachi, J., Horikoshi, Y., Shibuya, A., Iwasaki, W., Tashiro, S., Tomonaga, T., and Siomi, H. (2021). Piwi-piRNA complexes induce stepwise changes in nuclear architecture at target loci. EMBO J, e108345.
  2. Kinoshita, M., Ogawa, Y., Hama, N., Ujiie, I., Hasegawa, A., Nakajima, S., Nomura, T., Adachi, J., Sato, T., Koizumi, S., et al. (2021). Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis. Sci Transl Med 13.
  3. Onidani, K., Miura, N., Sugiura, Y., Abe, Y., Watabe, Y., Kakuya, T., Mori, T., Yoshimoto, S., Adachi, J., Kiyoi, T., et al. (2021). Possible Therapeutic Strategy Involving the Purine Synthesis Pathway Regulated by ITK in Tongue Squamous Cell Carcinoma. Cancers (Basel) 13.
  4. Yamashita, S., Kimiwada, T., Hayashi, T., Shirane, R., and Tomonaga, T. (2021). Reconversion to ventriculoperitoneal shunt following ventriculoatrial shunt malfunction in children. Childs Nerv Syst 37, 2207-2213.
  5. Koba, T., Takeda, Y., Narumi, R., Shiromizu, T., Nojima, Y., Ito, M., Kuroyama, M., Futami, Y., Takimoto, T., Matsuki, T., Edahiro, R., Nojima, S., Hayama, Y., Fukushima, K., Hirata, H., Koyama, S., Iwahori, K., Nagatomo, I., Suzuki, M., Shirai, Y., Murakami, T., Nakanishi, K., Nakatani, T., Suga, Y., Miyake, K., Shiroyama, T., Kida, H., Sasaki, T., Ueda, K., Mizuguchi, K., Adachi, J., Tomonaga, T., and Kumanogoh, A. (2021). Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres. ERJ Open Res 7.
  6. Saika, A., Nagatake, T., Hirata, S.I., Sawane, K., Adachi, J., Abe, Y., Isoyama, J., Morimoto, S., Node, E., Tiwari, P., Hosomi, K., Matsunaga, A., Honda, T., Tomonaga, T., Arita, M., Kabashima, K., and Kunisawa, J. (2021). omega3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor alpha. FASEB J 35, e21354.
  7. Sugimoto, A., Abe, Y., Watanabe, T., Hosokawa, K., Adachi, J., Tomonaga, T., Iwatani, Y., Murata, T., and Fujimuro, M. (2021). The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus. J Virol.
  8. Tomiyama, E., Matsuzaki, K., Fujita, K., Shiromizu, T., Narumi, R., Jingushi, K., Koh, Y., Matsushita, M., Nakano, K., Hayashi, Y., Wang, C., Ishizuya, Y., Kato, T., Hatano, K., Kawashima, A., Ujike, T., Uemura, M., Takao, T., Adachi, J., Tomonaga, T., and Nonomura, N. (2021). Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers. Cancer Sci.
  9. Morii, M., Kubota, S., Hasegawa, C., Takeda, Y., Kometani, S., Enomoto, K., Suzuki, T., Yanase, S., Sato, R., Akatsu, A., Hirata, K., Honda, T., Kuga, T., Tomonaga, T., Nakayama, Y., and Yamaguchi, N. (2021). Src-mediated tyrosine phosphorylation of PRC1 and kinastrin/SKAP on the mitotic spindle. Sci Rep 11, 2616.
  10. Hara, Y., Zhang, B., Suzuki, A., Yamaguchi, S., Adachi, J., Tomonaga, T., Yasunaga, S., Saku, K., Aoyama, T., and Hirano, K.I. (2020). Effect of Tricaprin on Cardiac Proteome in a Mouse Model for Triglyceride Deposit Cardiomyovasculopathy. J Oleo Sci 69, 1569-1577.
  11. Monoe, Y., Jingushi, K., Kawase, A., Hirono, T., Hirose, R., Nakatsuji, Y., Kitae, K., Ueda, Y., Hase, H., Abe, Y., Adachi, J., Tomonaga, T., and Tsujikawa, K. (2021). Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1. Int J Mol Sci 22

新技術